Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
11,858,332
-
Share change
-
+5,206,982
-
Total reported value
-
$42,923,601
-
Put/Call ratio
-
34%
-
Price per share
-
$3.62
-
Number of holders
-
39
-
Value change
-
+$18,706,884
-
Number of buys
-
26
-
Number of sells
-
8
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) as of Q4 2016
As of 31 Dec 2016,
SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,858,332 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, BVF INC/IL, NEA Management Company, LLC, Palo Alto Investors, LLC, DAFNA Capital Management LLC, Cormorant Asset Management, LLC, BAKER BROS. ADVISORS LP, First Eagle Investment Management, LLC, Boxer Capital, LLC, and Vivo Capital, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.